Latest Options News

Torque Metals has completed its acquisition of Aston Minerals through court-approved schemes of arrangement, leading to Aston's delisting from the ASX and a reshaped leadership team for the combined entity.

Aguia Resources has locked in $750,000 through convertible notes to bolster working capital, pending shareholder approval expected in mid-July. The notes carry a 10% interest rate and come with free options, signaling cautious optimism about the company’s near-term funding needs.

Sunrise Energy Metals Limited has announced a $1.5 million Share Purchase Plan (SPP) offering eligible shareholders the chance to invest at 30 cents per share, accompanied by options exercisable at 40 cents until May 2027. The capital raise aims to fast-track the feasibility study and development of its Syerston Scandium Project in New South Wales.

Dalaroo Metals has secured an option to acquire up to 80% of the Bongouanoa Gold Project in Cote d’Ivoire, tapping into a richly mineralised region with strong historical drill results and high-grade gold anomalies.

Breakthrough Minerals has completed the acquisition of the Errolls Gold Project in Western Australia and raised $1.2 million to fund an upcoming drilling program targeting high-grade gold mineralisation.

Eclipse Metals has successfully raised $2 million through an oversubscribed placement at market price, aiming to accelerate exploration and environmental work at its Grønnedal rare earth project in Greenland.

Bowen Coking Coal is set to transition its Burton Mine Complex to an owner-operator model from July 1, 2025, aiming to increase production and reduce costs. This strategic shift marks a new chapter in Bowen’s operational control and growth ambitions.

S2 Resources has raised A$3.5 million through a placement and share purchase plan to fund exploration across multiple Australian gold and base metal projects. The capital injection aims to maintain momentum while balancing shareholder interests.

Syntara Limited’s lead drug candidate SNT-5505 has secured FDA Fast Track designation, expediting its development for treating myelofibrosis, a rare and serious blood cancer with limited therapies.

Centrex Limited’s creditors are set to decide on a proposed restructuring plan by PRL Global Limited that could reshape the company’s future and creditor recoveries.

Pure Foods Tasmania has raised $100,000 through a share placement and appointed directors to new operational roles aimed at driving sales growth and improving cost efficiency.

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.